Tumor-Infiltrating Lymphocytes and Associations With Pathological Complete Response and Event-Free Survival in HER2-Positive Early-Stage Breast Cancer Treated With Lapatinib and Trastuzumab: A Secondary Analysis of the NeoALTTO Trial (Q38407917)
Jump to navigation
Jump to search
scientific article published on July 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Tumor-Infiltrating Lymphocytes and Associations With Pathological Complete Response and Event-Free Survival in HER2-Positive Early-Stage Breast Cancer Treated With Lapatinib and Trastuzumab: A Secondary Analysis of the NeoALTTO Trial |
scientific article published on July 2015 |
Statements
1 reference
Tumor-Infiltrating Lymphocytes and Associations With Pathological Complete Response and Event-Free Survival in HER2-Positive Early-Stage Breast Cancer Treated With Lapatinib and Trastuzumab: A Secondary Analysis of the NeoALTTO Trial (English)
1 reference
1 reference
Jose Baselga
1 reference
Claudia Aura
1 reference
Holger Eidtmann
1 reference
Roberto Salgado
1 reference
Christine Campbell
1 reference
Peter Savas
1 reference
Catherine E Ellis
1 reference
Martine J Piccart-Gebhart
1 reference
Ian Bradbury
1 reference
Christos Sotiriou
1 reference
1 July 2015
1 reference
1 reference
448-454
1 reference
Identifiers
1 reference
1 reference
1 reference